James R. Empfield net worth and biography

James Empfield Biography and Net Worth

Dr. Empfield joined Xenon in 2016 and is employed by our wholly owned subsidiary, Xenon Pharmaceuticals USA Inc., as our Executive Vice President, Drug Discovery. Prior to joining us, Dr. Empfield served as Vice President, Drug Discovery and Chemistry; Co-Site Head of Research, Boston at Vertex Pharmaceuticals Inc. from 2011 until August 2015, where he was jointly responsible for the entire Boston research organization and for delivery of lead optimization projects into preclinical development. From 2006 to 2011, Dr. Empfield was Director, CNS Chemistry Department at Astrazeneca Pharmaceuticals LP and held various other positions at Astrazeneca Pharmaceuticals from 1990 to 2006. Dr. Empfield has a Ph.D. in Chemistry from the University of Pennsylvania, a M.S. in Chemistry from Bucknell University and a B.Sc. in Chemistry from Lebanon Valley College.

What is James R. Empfield's net worth?: The estimated net worth of James R. Empfield is at least $383,100.00 as of August 12th, 2022. Dr. Empfield owns 10,000 shares of Xenon Pharmaceuticals stock worth more than $383,100 as of November 18th. This net worth evaluation does not reflect any other assets that Dr. Empfield may own. Additionally, Dr. Empfield receives a salary of $323,430.00 as EVP at Xenon Pharmaceuticals. Learn More about James R. Empfield's net worth.
How old is James R. Empfield?: Dr. Empfield is currently 63 years old. There are 6 older executives and no younger executives at Xenon Pharmaceuticals. The oldest executive at Xenon Pharmaceuticals is Ms. Shelley McCloskey B.A., Executive Vice President of Human Resources, who is 64 years old. Learn More on James R. Empfield's age.
What is James R. Empfield's salary?: As the EVP of Xenon Pharmaceuticals Inc., Dr. Empfield earns $323,430.00 per year. There are 5 executives that earn more than Dr. Empfield. The highest earning executive at Xenon Pharmaceuticals is Mr. Ian C. Mortimer C.M.A., CPA, M.B.A., President, CEO & Director, who commands a salary of $1,070,000.00 per year. Learn More on James R. Empfield's salary.
How do I contact James R. Empfield?: The corporate mailing address for Dr. Empfield and other Xenon Pharmaceuticals executives is 200 - 3650 GILMORE WAY, BURNABY A1, V5G 48W. Xenon Pharmaceuticals can also be reached via phone at (604) 484-3300 and via email at [email protected]. Learn More on James R. Empfield's contact information.
Has James R. Empfield been buying or selling shares of Xenon Pharmaceuticals?: James R. Empfield has not been actively trading shares of Xenon Pharmaceuticals over the course of the past ninety days. Most recently, James R. Empfield sold 57,743 shares of the business's stock in a transaction on Friday, August 12th. The shares were sold at an average price of $38.31, for a transaction totalling $2,212,134.33. Following the completion of the sale, the executive vice president now directly owns 10,000 shares of the company's stock, valued at $383,100. Learn More on James R. Empfield's trading history.
Who are Xenon Pharmaceuticals' active insiders?: Xenon Pharmaceuticals' insider roster includes James Empfield (EVP), Steven Gannon (Director), Frank Holler (Director), Christopher Kenney (Insider), Ian Mortimer (President and Chief Executive Officer), Gary Patou (Director), Simon Pimstone (Director), Robin Sherrington (EVP), Dawn Svoronos (Director), and Christopher Von Seggern (Insider). Learn More on Xenon Pharmaceuticals' active insiders.
Are insiders buying or selling shares of Xenon Pharmaceuticals?: In the last year, insiders at the biopharmaceutical company sold shares 3 times. They sold a total of 31,517 shares worth more than $1,379,060.56. The most recent insider tranaction occured on March, 7th when EVP Sherrington Robin sold 7,137 shares worth more than $330,300.36. Insiders at Xenon Pharmaceuticals own 5.5% of the company. Learn More about insider trades at Xenon Pharmaceuticals.
Information on this page was last updated on 3/7/2024.

James R. Empfield Insider Trading History at Xenon Pharmaceuticals

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
8/12/2022	Sell	57,743	$38.31	$2,212,134.33	10,000
3/7/2022	Sell	32,853	$30.54	$1,003,330.62
8/15/2017	Buy	10,000	$2.48	$24,800.00	10,000

James R. Empfield Buying and Selling Activity at Xenon Pharmaceuticals

Xenon Pharmaceuticals Company Overview

Xenon Pharmaceuticals Inc., a neuroscience-focused biopharmaceutical company, engages in the development of therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN1101, a novel and potent Kv7 potassium channel opener, which is in Phase 3 clinical trials for the treatment of epilepsy and other neurological disorders. The company has a license and collaboration agreement with the Neurocrine Biosciences, Inc. for the development of NBI-921352, a selective Nav1.6 sodium channel inhibitor that is in Phase 2 clinical trials for the treatment of SCN8A developmental and epileptic encephalopathy, and other indications, including adult focal epilepsy. Xenon Pharmaceuticals Inc. was incorporated in 1996 and is headquartered in Burnaby, Canada.

Today's Range

Now: $38.31

$37.38

$40.01

50 Day Range

MA: $41.21

$38.06

$45.74

2 Week Range

Now: $38.31

$28.20

$50.99

Volume

878,189 shs

Average Volume

389,378 shs

Market Capitalization

$2.92 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.25

DeFi Coin on Verge of Breakout!

From Crypto 101 Media | Ad

The blueprint for millionaires is here. Don't let this be the missed opportunity you regret for years.

Claim your FREE book now before it's too late!

James Empfield Biography and Net Worth

What is James R. Empfield's net worth?

How old is James R. Empfield?

What is James R. Empfield's salary?

How do I contact James R. Empfield?

Has James R. Empfield been buying or selling shares of Xenon Pharmaceuticals?

Who are Xenon Pharmaceuticals' active insiders?

Are insiders buying or selling shares of Xenon Pharmaceuticals?